IRIX | IRIDEX Corporation | [NASD]
Index- P/E- EPS (ttm)-0.45 Insider Own1.50% Shs Outstand16.00M Perf Week-7.50%
Market Cap37.00M Forward P/E- EPS next Y-0.23 Insider Trans0.00% Shs Float11.73M Perf Month-5.27%
Income-7.20M PEG- EPS next Q-0.11 Inst Own26.00% Short Float / Ratio0.41% / 3.01 Perf Quarter-6.90%
Sales57.30M P/S0.65 EPS this Y-39.80% Inst Trans-0.02% Short Interest0.05M Perf Half Y-0.00%
Book/sh0.99 P/B2.18 EPS next Y37.10% ROA-16.70% Target Price4.62 Perf Year-29.64%
Cash/sh0.64 P/C3.36 EPS next 5Y30.00% ROE-41.00% 52W Range1.96 - 3.49 Perf YTD7.46%
Dividend- P/FCF- EPS past 5Y15.70% ROI-44.20% 52W High-38.11% Beta1.23
Dividend %- Quick Ratio1.80 Sales past 5Y6.50% Gross Margin44.20% 52W Low10.20% ATR0.10
Employees130 Current Ratio2.60 Sales Q/Q2.20% Oper. Margin-13.30% RSI (14)39.47 Volatility5.92% 3.80%
OptionableYes Debt/Eq0.00 EPS Q/Q13.20% Profit Margin-12.60% Rel Volume0.67 Prev Close2.31
ShortableYes LT Debt/Eq0.00 EarningsMay 11 AMC Payout- Avg Volume16.07K Price2.16
Recom2.50 SMA20-5.96% SMA50-2.04% SMA200-6.41% Volume10,800 Change-6.50%
Date Action Analyst Rating Change Price Target Change
Nov-03-17Resumed ROTH Capital Buy
Dec-21-16Initiated ROTH Capital Buy
Jan-26-16Initiated Singular Research Buy $11.50
Jan-03-07Initiated First Albany Buy $15.50
May-18-23 08:50AM
May-12-23 06:37AM
May-11-23 06:05PM
Apr-27-23 04:05PM
02:37PM Loading…
Apr-21-23 02:37PM
Apr-12-23 07:00AM
Mar-13-23 01:58AM
Mar-10-23 06:27AM
Mar-09-23 05:55PM
Mar-07-23 04:05PM
Mar-02-23 09:00AM
Feb-23-23 04:05PM
04:05PM Loading…
Jan-10-23 04:05PM
Dec-06-22 05:07PM
Nov-13-22 07:48AM
Nov-10-22 06:35PM
Nov-03-22 06:53AM
Oct-27-22 04:05PM
Sep-29-22 04:05PM
Sep-23-22 07:55AM
Sep-07-22 05:09PM
Aug-18-22 04:05PM
Aug-15-22 05:25PM
Aug-09-22 08:36AM
Aug-01-22 04:05PM
02:49PM Loading…
Jul-27-22 02:49PM
Jun-14-22 09:21AM
May-12-22 06:05PM
May-10-22 05:25PM
May-05-22 09:25AM
May-03-22 09:15AM
Apr-28-22 04:05PM
Mar-21-22 04:05PM
Mar-10-22 05:55PM
Mar-08-22 05:02PM
Feb-24-22 04:05PM
Jan-11-22 04:05PM
Jan-04-22 06:32AM
Nov-12-21 08:00AM
Nov-11-21 04:05PM
Nov-08-21 09:55AM
Nov-06-21 12:44PM
Nov-04-21 03:01PM
Oct-28-21 04:05PM
Sep-30-21 04:05PM
Sep-21-21 09:47AM
Sep-08-21 08:47AM
Aug-12-21 06:35PM
Aug-09-21 04:05PM
Jul-29-21 04:05PM
Jun-23-21 03:55AM
Jun-13-21 10:58PM
May-11-21 04:05PM
May-04-21 03:00PM
Apr-27-21 04:05PM
Mar-23-21 12:52PM
Mar-22-21 05:43PM
Mar-19-21 10:46AM
Mar-15-21 12:30PM
Mar-10-21 04:05PM
Mar-08-21 04:05PM
Mar-04-21 12:30PM
Mar-02-21 04:05PM
Jan-14-21 01:36AM
Jan-11-21 04:05PM
Dec-22-20 04:05PM
Nov-11-20 06:41AM
Nov-09-20 06:35PM
Nov-06-20 10:19AM
Nov-03-20 04:05PM
Nov-02-20 12:31PM
Oct-26-20 04:05PM
Aug-19-20 02:53PM
Aug-06-20 04:05PM
Jul-30-20 12:33PM
Jul-23-20 04:05PM
Jun-16-20 03:44AM
May-16-20 10:05AM
May-11-20 08:15PM
Apr-28-20 05:31PM
Apr-21-20 08:00AM
Mar-30-20 04:05PM
Mar-28-20 12:11AM
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.